Traws Pharma, Inc. TRAW
0.56
0.00
0.00%
as of 25 Sep
- Market cap
- $7.3M
- P/E
- 0.0×
Follow TRAW
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 |
P/S ratio |
1.80 | 17.15 | 7.09 | 2.51 | 354.10 | 189.92 | 65.68 | 73.37 | 61.01 | 3.27 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(2.29) | (2.89) | (1.61) | (1.02) | (14.96) | (10.06) | (3.82) | (3.74) | (3.41) | (3.37) |
P/B ratio |
1.95 | 0.00 | 1.62 | 0.47 | 13.25 | 0.93 | 0.52 | 1.55 | 0.00 | 0.00 |
Price to Tangible BV |
1.95 | 0.00 | 1.62 | 0.47 | 13.25 | 0.93 | 0.52 | 1.55 | 0.00 | 0.00 |
EV/Sales |
(2.07) | 12.04 | (6.73) | (7.90) | 271.74 | (53.75) | (105.81) | (18.76) | (33.41) | 1.92 |
EV/EBITDA |
0.49 | 0.00 | 0.36 | 0.80 | 0.00 | 0.74 | 1.22 | 0.21 | 0.05 | 0.00 |
EV/Operating CF |
0.72 | (0.40) | 0.36 | 0.83 | (2.72) | 0.62 | 1.47 | 0.24 | 0.25 | (0.30) |
EV/FCF |
0.71 | (0.39) | 0.36 | 0.83 | (2.72) | 0.62 | 1.47 | 0.24 | 0.25 | (0.30) |
Quick Ratio |
2.11 | 0.41 | 2.02 | 2.75 | 1.90 | 9.01 | 4.82 | 2.26 | 2.00 | 0.68 |
Current Ratio |
2.27 | 0.49 | 2.11 | 2.83 | 1.97 | 9.06 | 4.89 | 2.46 | 2.16 | 0.72 |
Net Debt/EBITDA |
0.91 | 0.16 | 0.73 | 1.05 | 0.76 | 3.34 | 1.98 | 1.03 | 0.15 | 0.21 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.24 | 0.06 | 0.11 | 0.11 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.16 |
Operating CF/Net income |
0.80 | 0.99 | 1.10 | 0.97 | 0.92 | 1.21 | 0.86 | 0.95 | 0.54 | (2.65) |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (3.93) | (1.15) | 0.00 | 0.00 | (0.87) | 0.00 | (42.38) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (246.35%) | 840.32% | 751.66% | (253.56%) | (283.48%) | (61.81%) | (50.96%) | (97.22%) | 521.75% | (42.56%) | |
| (84.27%) | (170.79%) | (179.66%) | (103.39%) | (115.24%) | (42.84%) | (39.99%) | (61.07%) | (229.51%) | 38.59% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(150.58%) | 480.97% | (220.36%) | (141.17%) | (256.31%) | (32.75%) | (60.54%) | (140.75%) | (407.16%) | (217.25%) |
Average Days of Receivables |
2.04 | 27.36 | 10.40 | 16.39 | 58.46 | 45.22 | 46.84 | 29.07 | 2,850.55 | 496.35 |
Research and Development Expense of Revenue |
361.90% | 2,429.35% | 1,378.18% | 711.73% | 7,315.15% | 3,228.76% | 5,046.90% | 5,057.52% | 57,659.73% | 435.23% |
Selling, General and Administrative Expense of Revenue |
165.49% | 940.91% | 617.75% | 382.27% | 3,604.33% | 4,170.35% | 3,737.61% | 4,023.89% | 5,437.61% | 305.45% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 |
Share Based Compensation of Revenue |
70.84% | 217.28% | 93.40% | 48.01% | 159.74% | 254.87% | 518.58% | 575.66% | 615.04% | 26.09% |
Graham Net Nets |
0.50 | (0.81) | 0.60 | 2.08 | 0.07 | 1.07 | 1.91 | 0.64 | (2.29) | (0.35) |
Graham Number |
0.00 | 49,184.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 136.92 | 0.00 |
Earnings Yield |
(246.93%) | (187.72%) | (375.82%) | (393.96%) | (27.65%) | (37.25%) | (128.17%) | (115.19%) | (460.59%) | 83.43% |
Free Cash Flow Yield |
(160.57%) | (178.13%) | (263.38%) | (381.80%) | (28.23%) | (45.43%) | (109.86%) | (108.23%) | (216.17%) | (195.73%) |
Revenue per Share |
6,932.50 | 491.88 | 111.64 | 56.85 | 0.50 | 0.34 | 0.27 | 0.27 | 0.15 | 0.34 |
Operating CF per Share |
(19,766.25) | (14,887.50) | (2,063.27) | (542.47) | (49.72) | (28.94) | (19.48) | (21.36) | (19.19) | (2.21) |
Capex per Share |
0.00 | 0.00 | 0.00 | (1.43) | (0.03) | 0.00 | 0.00 | (0.02) | 0.00 | (0.31) |
Free Cash Flow per Share |
(19,766.25) | (14,887.50) | (2,063.27) | (543.91) | (49.75) | (28.94) | (19.48) | (21.37) | (19.19) | (2.52) |
Cash per Share |
26,812.50 | 2,515.00 | 1,542.73 | 591.82 | 40.99 | 81.79 | 46.34 | 24.80 | 13.74 | 0.46 |
Shareholders Equity per Share |
6,408.75 | (6,788.12) | 489.73 | 301.41 | 13.31 | 68.50 | 33.85 | 12.71 | (20.37) | (0.08) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6,408.75 | (6,788.12) | 489.73 | 301.41 | 13.31 | 68.50 | 33.85 | 12.71 | (20.37) | (0.08) |
Free Cash Flow |
(15.81) | (23.82) | (22.70) | (20.89) | (23.09) | (19.49) | (16.29) | (17.95) | (29.79) | (20.77) |
Working Capital |
12.91 | (5.07) | 9.33 | 15.18 | 9.76 | 49.32 | 31.30 | 13.44 | 13.42 | (3.17) |
Capital Expenditures |
— | — | — | (0.05) | (0.01) | — | — | (0.01) | — | (2.58) |
Net Current Asset Value |
4.96 | (10.94) | 5.23 | 11.37 | 5.97 | 46.07 | 28.28 | 10.65 | (31.64) | (3.27) |
EV/EBIT |
0.48 | 0.00 | 0.36 | 0.80 | 0.00 | 0.74 | 1.22 | 0.21 | 0.05 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.03 | 0.06 | 0.00 | 0.00 | 0.06 | 0.00 | 0.93 |
Net Profit Margin |
(354.62%) | (3,061.25%) | (1,675.33%) | (985.02%) | (10,890.48%) | (7,151.77%) | (8,391.15%) | (8,384.07%) | (24,192.04%) | 246.06% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.63 | 1.38 | 6.11 | 0.28 | 0.25 | 0.37 | 0.58 | 0.73 | 1.20 | 8.71 |
Cash ROIC |
(60.07%) | 349.33% | (101.56%) | (60.88%) | (91.77%) | (19.30%) | (24.33%) | (57.01%) | 289.56% | (570.10%) |
Accounts Receivable Turnover |
7.23 | 17.49 | 26.13 | 32.83 | 3.42 | 6.95 | 7.93 | 9.62 | 0.25 | 1.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.77 | 0.05 | 0.05 | 0.07 | 0.07 | 0.03 | 0.03 | 0.02 | 0.89 | 2.78 |
Average Payables |
4.37 | 5.75 | 5.11 | 4.16 | 4.55 | 3.80 | 3.31 | 4.74 | 6.90 | 6.92 |
Average Assets |
23.34 | 14.11 | 11.45 | 20.80 | 21.83 | 37.73 | 47.43 | 31.03 | 23.82 | 17.79 |
Average Common Equity |
7.98 | (2.87) | (2.74) | 8.48 | 8.87 | 26.15 | 37.21 | 19.49 | (10.48) | (16.13) |
Columns are period end dates